Literature DB >> 12866043

Magnetic resonance imaging of the pancreas and pancreatic tumors in a mouse orthotopic model of human cancer.

Jan Grimm1, Andreas Potthast, Andreas Wunder, Anna Moore.   

Abstract

Pancreatic adenocarcinoma has a rising incidence and a very poor survival rate. To develop new treatment strategies, extensive research is performed on animal models of pancreatic cancer. Orthotopic pancreatic tumors models, where the tumor is implanted into the pancreas, resemble the human disease more closely than subcutaneous tumor models, yet are difficult to monitor. In our study we report a magnetic resonance imaging (MRI) approach to visualize the pancreas in mice and to monitor orthotopically implanted pancreatic tumors. An MRI scanner was used to image normal murine pancreas and the pancreas of mice implanted with a human pancreatic adenocarcinoma cell line. Gadolinium (Gd)-DTPA-enhanced T1- and T2-weighted standard sequences were used with the objective to identify the pancreas and to monitor the growth of orthotopic tumors during 30 days. The pancreas as well as the implanted tumors could be easily identified using MRI. On T2-weighted images, the implanted tumors were easily visualized at the implantation side with high signal intensity. After application of a contrast agent, the tumors showed an enhancement. Heterogeneities within the tumor could be delineated, corresponding to histology, and the size of the tumor could be measured precisely. MR serves as a noninvasive high-resolution image modality to monitor murine pancreas as well as size, growth and even areas of heterogeneity in orthotopic pancreatic tumors. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12866043     DOI: 10.1002/ijc.11281

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

1.  In vivo proton MR spectroscopy of pancreatic neuroendocrine tumors in a multiple endocrine neoplasia type 1 conditional knockout mouse model.

Authors:  Min-Hui Cui; Craig A Branch; Sean M Cahill; Thomas J Quinn; Asha Adem; Steven K Libutti; Ziqiang Yuan
Journal:  Magn Reson Med       Date:  2014-11-13       Impact factor: 4.668

2.  Targeted nanogels: a versatile platform for drug delivery to tumors.

Authors:  Eric A Murphy; Bharat K Majeti; Rajesh Mukthavaram; Lisette M Acevedo; Leo A Barnes; David A Cheresh
Journal:  Mol Cancer Ther       Date:  2011-04-25       Impact factor: 6.261

3.  Gd(III)-Dithiolane Gold Nanoparticles for T1-Weighted Magnetic Resonance Imaging of the Pancreas.

Authors:  Robert J Holbrook; Nikhil Rammohan; Matthew W Rotz; Keith W MacRenaris; Adam T Preslar; Thomas J Meade
Journal:  Nano Lett       Date:  2016-04-20       Impact factor: 11.189

4.  Visualization of mouse pancreas architecture using MR microscopy.

Authors:  Paul J Grippo; Palamadai N Venkatasubramanian; Richard H Knop; Daniel M Heiferman; Gheorghe Iordanescu; Laleh G Melstrom; Kevin Adrian; Morgan R Barron; David J Bentrem; Alice M Wyrwicz
Journal:  Am J Pathol       Date:  2011-05-31       Impact factor: 4.307

5.  Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model.

Authors:  Subrata K Ghosh; Masashi Uchida; Byunghee Yoo; Alana W Ross; Sandra J Gendler; Jianlin Gong; Anna Moore; Zdravka Medarova
Journal:  Int J Cancer       Date:  2012-10-25       Impact factor: 7.396

6.  Imaging tumor variation in response to photodynamic therapy in pancreatic cancer xenograft models.

Authors:  Kimberley S Samkoe; Alina Chen; Imran Rizvi; Julia A O'Hara; P Jack Hoopes; Stephen P Pereira; Tayyaba Hasan; Brian W Pogue
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-01-01       Impact factor: 7.038

7.  RBBP9: a tumor-associated serine hydrolase activity required for pancreatic neoplasia.

Authors:  David J Shields; Sherry Niessen; Eric A Murphy; Ainhoa Mielgo; Jay S Desgrosellier; Steven K M Lau; Leo A Barnes; Jacqueline Lesperance; Michael Bouvet; David Tarin; Benjamin F Cravatt; David A Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

8.  Empirical mathematical model for dynamic manganese-enhanced MRI of the murine pancreas for assessment of β-cell function.

Authors:  Anita H Dhyani; Xiaobing Fan; Lara Leoni; Muhammad Haque; Brian B Roman
Journal:  Magn Reson Imaging       Date:  2012-10-25       Impact factor: 2.546

9.  Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis.

Authors:  Eric A Murphy; Bharat K Majeti; Leo A Barnes; Milan Makale; Sara M Weis; Kimberly Lutu-Fuga; Wolfgang Wrasidlo; David A Cheresh
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-07       Impact factor: 11.205

10.  Noninvasive assessment of pancreatic beta-cell function in vivo with manganese-enhanced magnetic resonance imaging.

Authors:  Patrick F Antkowiak; Sarah A Tersey; Jeffrey D Carter; Moriel H Vandsburger; Jerry L Nadler; Frederick H Epstein; Raghavendra G Mirmira
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-30       Impact factor: 4.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.